Table 4.
CKD + SCH (baseline TSH > 10 mIU/L): CKD progression at 6, 12, 18, and 24 months
n = 25 | P value | SMD | ||||
---|---|---|---|---|---|---|
Treatment cohort (n = 15) | Nontreatment cohort (n = 10) | |||||
n | % | n | % | |||
CKD progression from BL at: | ||||||
6 months | 1 | 6.7 | 3 | 30.0 | 0.1190 | 60.3 |
12 months | 2 | 13.3 | 3 | 30.0 | 0.3074 | 39.4 |
18 months | 3 | 20.0 | 4 | 40.0 | 0.2752 | 42.7 |
24 months | 3 | 20.0 | 5 | 50.0 | 0.1152 | 63.3 |
BL baseline, CKD chronic kidney disease, SCH subclinical hypothyroidism, SMD standardized mean difference, TSH thyroid-stimulating hormone